AndhraNews.net
Home » Business News » 2013 » March » March 11, 2013

Global Anticoagulants Market to Spike to Over $24 Billion by 2019


March 11, 2013 - NEW YORK, NY

TriMarkPublications.com cites in its newly published "New Oral Anticoagulants Markets" report that the global anticoagulants market will spike to over $24 billion by 2019. For more information, visit: http://www.trimarkpublications.com/new-oral-anticoagulants-markets/.

Anticoagulants can be categorized into five main modalities: low molecular weight heparins (LMWHs), herapins, warfarin, direct thrombin inhibitors (DTIs) and factor Xa inhibitors. The U.S. anticoagulants market, which encompasses over 60% of the global market for anticoagulants, will grow from $7.06 billion in 2012 to $15.32 billion in 2019 as it shifts from being monopolized by a single injectable anticoagulant, warfarin, to once-daily oral anticoagulants.

The "New Oral Anticoagulants Markets" report covers:

  • Dabigatran (Pradaxa)
  • Rivaroxaban (Xarelto)
  • Eliquis (Apixaban)
  • Edoxaban
  • Betrixaban
  • Antiplatelets
  • Clotting Assays
  • Cardiovascular Diseases
  • Cardiac Arrhythmia
  • Coronary Artery Disease
  • Myocardial Infarction
  • Heart Valve Replacement
  • Deep Vein Thrombosis (DVT)

The "New Oral Anticoagulants Markets" report examines companies manufacturing anticoagulant equipment and supplies in the world. Companies covered include: Akers, Anthera, ARYx, AstraZeneca, Boehringer Ingelheim, Cipla, Daiichi Sankyo, Eisai, Eli Lilly, Genentech, GlaxoSmithKline, Medicines Company, Medicure, Merck, Novartis, Ortho-McNeil, Pfizer, Pharmion, Portola and Sanofi.

Detailed charts with sales forecasts and marketshare data are included. For more information, visit: http://www.trimarkpublications.com/new-oral-anticoagulants-markets/.

About TriMarkPublications.com

TriMarkPublications.com is a global leader in the biotechnology, healthcare and life sciences market research publishing. For more information, please visit http://www.trimarkpublications.com.

Important Notice

The statements contained in this news release that are forward-looking are based on current expectations that are subject to a number of uncertainties and risks, and actual results may differ materially.

Add to Digg Bookmark with del.icio.us Add to Newsvine

Contact

TriMarkPublications.com
Media Relations
1-888-OK-TRIMARK
www.trimarkpublications.com

MarketWire

Comment on this story

Share